ストックスクリーナーアプリを入手
0.4801
2.83%
-0.0139
前日終値:
$0.494
開ける：
$0.47
24時間の取引高:
256.86K
Relative Volume:
0.55
時価総額：
$21.47M
収益：
$106.79M
当期純損益:
$-8.73M
株価収益率:
-2.4005
EPS:
-0.2
ネットキャッシュフロー:
$10.81M
1週間 パフォーマンス:
-12.73%
1か月 パフォーマンス:
-13.45%
6か月 パフォーマンス:
+8.70%
1年 パフォーマンス:
-25.01%
1日の値動き範囲:
$0.459
$0.4906
1週間の範囲:
$0.40
$0.5422
52週間の値動き範囲:
$0.2813
$0.9458
Harvard Bioscience Inc Stock (HBIO) Company Profile
名前
Harvard Bioscience Inc
セクター
電話
(508) 893-8999
住所
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO vs ISRG, BDX, ALC, RMD, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.4801 | 22.09M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
472.15 | 170.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.99 | 45.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
76.98 | 38.26B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
231.53 | 33.86B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.30 | 33.33B | 28.43B | 1.16B | 1.26B | 1.4457 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-09 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | アップグレード | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | アップグレード | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | 開始されました | Northland Capital | Outperform |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | ダウングレード | Janney | Buy → Neutral |
| 2018-01-24 | 繰り返されました | Janney | Buy |
| 2018-01-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-11-17 | 開始されました | Singular Research | Buy |
| 2015-07-28 | 開始されました | The Benchmark Company | Buy |
すべてを表示
Harvard Bioscience Inc (HBIO) 最新ニュース
HBIO: Analyst Bruce D. Jackson Maintains Rating but Lowers Price Target | HBIO Stock News - GuruFocus
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript - Insider Monkey
Harvard Bioscience 2025 10‑K: Revenue $86.6M, Gross Profit $49.91M - TradingView
Benchmark cuts Harvard Bioscience stock price target on NIH concerns - Investing.com
Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high - Investing.com
Harvard Bioscience Q4 2025 Earnings Call Transcript - MarketBeat
Harvard Bioscience, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Harvard Bioscience: Q4 Earnings Snapshot - Chron
Harvard Bioscience (HBIO) Earnings Transcript - AOL.com
Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth By Investing.com - Investing.com Nigeria
Harvard Bioscience earnings missed by $0.10, revenue topped estimates - Investing.com Canada
Harvard Bioscience Q4 & Annual Financial Results 2025News and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Harvard Bioscience (HBIO) Reports Q4 Loss of $0.06/Share, Revenue Falls 3.3% to $23.7M - AlphaStreet
Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth - Investing.com
HBIO Projects Robust EBITDA Growth for 2026 - GuruFocus
Harvard Bioscience (HBIO) Reports Slight Dip in Q4 Revenue as St - GuruFocus
HBIO Projects Adjusted EBITDA Growth for Upcoming Period - GuruFocus
Harvard Bioscience: Fourth Quarter Financial Results Overview - Bitget
Harvard Bioscience Reports Q4 Revenue $23.7M, FY2025 Revenue $86.6M and Improved Gross Margins - TradingView
HARVARD BIOSCIENCE ($HBIO) Releases Q4 2025 Earnings - Quiver Quantitative
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - Bluefield Daily Telegraph
Harvard Bioscience promotes Frost to CFO - Worcester Business Journal
Harvard Bioscience Amends Executive Employment Agreements for CEO John Duke and CFO Mark Frost – Key Terms and Provisions - Minichart
Harvard Bioscience Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView
Harvard Bioscience Updates Executive Contracts and Finance Leadership - TipRanks
Harvard Bioscience Announces Reverse Stock Split - 富途牛牛
Harvard Bioscience Sets 1-for-10 Reverse Stock Split; Shares Drop 12% Overnight - Nasdaq
Aug Volume: Can Harvard Bioscience Inc grow without external funding2026 Closing Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn
Harvard Bioscience executes 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria
Bank Watch: Can Harvard Bioscience Inc navigate macro headwindsTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Harvard Bioscience executes 1-for-10 reverse stock split - Investing.com
Bull Bear: Does Harvard Bioscience Inc offer margin of safetyJuly 2025 PreEarnings & Free Reliable Trade Execution Plans - baoquankhu1.vn
Harvard Bioscience Approves Reverse Stock Split to Regain Compliance - TipRanks
Harvard Bioscience Announces 1-for-10 Reverse Stock Split Effective March 13, 2026 - Quiver Quantitative
Harvard Bioscience announces reverse stock split - marketscreener.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Harvard Bioscience to turn 10 shares into 1 in March split - Stock Titan
Harvard Bioscience (HBIO) to Release Quarterly Earnings on Thursday - Defense World
Harvard Bioscience (NASDAQ:HBIO) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum - The Manila Times
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET - ChartMill
Aug Breakouts: Is Harvard Bioscience Inc stock trending bullishJuly 2025 Earnings & Real-Time Market Sentiment Reports - baoquankhu1.vn
Is Harvard Bioscience Inc. a cyclical or defensive stockBond Market & Fast Gain Stock Tips - mfd.ru
Volume Report: Is Harvard Bioscience Inc exposed to political riskDividend Hike & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
What makes Harvard Bioscience Inc. stock attractive to growth fundsJuly 2025 Setups & Verified Trade Idea Suggestions - mfd.ru
Is Harvard Bioscience Inc. stock forming a triangle patternJuly 2025 Market Mood & Daily Entry Point Alerts - mfd.ru
How Harvard Bioscience Inc. stock reacts to Fed rate cutsJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - mfd.ru
HBIO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
HBIO Should I Buy - Intellectia AI
Is Harvard Bioscience Inc. forming a bullish divergenceWeekly Trade Analysis & High Accuracy Swing Trade Signals - mfd.ru
Why Harvard Bioscience Inc. stock could be next big winnerWeekly Profit Summary & Long Hold Capital Preservation Plans - mfd.ru
Harvard Bioscience Inc (HBIO) 財務データ
収益
当期純利益
現金流量
EPS
0.94%
0.01%
大文字化:
|
ボリューム (24 時間):